'It's going to shorten your life': framing of oncologist-patient communication about prognosis
In this qualitative study, we used grounded theory techniques to analyze transcripts of 29 first‐time encounters between oncologists and patients referred to them with previously diagnosed, incurable cancer. We found that 23 (79%) of the transcripts included 166 examples of prognostic talk. The lang...
Saved in:
Published in | Psycho-oncology (Chichester, England) Vol. 17; no. 3; pp. 219 - 225 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.03.2008
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In this qualitative study, we used grounded theory techniques to analyze transcripts of 29 first‐time encounters between oncologists and patients referred to them with previously diagnosed, incurable cancer. We found that 23 (79%) of the transcripts included 166 examples of prognostic talk. The language used ranged from general to personal, with 25% of statements mentioning no patients (e.g., ‘the tumor will usually come back’), 13% mentioning patients other than the current patient (e.g., ‘some patients with tumor response will be around for 2–5 years’), 11% mentioning the current patient in the context of others (e.g., ‘on average, people like you live a couple of years’), and 51% directly focusing on the patient (e.g., ‘this thing's going to kill you eventually’). More statements pertained to treatment‐related prognosis than to disease‐related prognosis (67 versus 33%). While 31% of statements focused on negative outcomes (loss framing), the remainder either focused on positive outcomes (gain framing) or discussed a combination of positive and negative outcomes (mixed framing). When discussions focused on negative outcomes, general and indirect language was commonly used, perhaps to buffer the patient from news of the poor prognosis. Copyright © 2007 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | ArticleID:PON1223 National Health and Medical Research Council of Australia (NH&MRC) - No. 950461 istex:E30B95B640E54CBD63D8FD7635371A9D1F638D66 VA HSR&D Merit Review Entry Program Award - No. MRP 04-410 National Cancer Institute - No. 3R01 CA100387-03S1 ark:/67375/WNG-3CNF5TCV-T ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 1057-9249 1099-1611 |
DOI: | 10.1002/pon.1223 |